Analysis

Paramount Global finds itself at a critical inflection point, implementing a dual-track approach of aggressive cost reduction and strategic expansion....

The biopharmaceutical firm Exelixis is generating significant attention with its developmental cancer treatment, Zanzalintinib. While the company already markets CABOMETYX...

Arvinas investors are bracing for what could prove to be the most consequential week of the year for the biotechnology...

While the broader aviation sector grapples with significant supply chain disruptions, Delta Air Lines continues to demonstrate remarkable operational resilience....

Investors eyeing FS KKR Capital's near-20% dividend yield face a sobering reality—the tantalizing income stream comes alongside severe share price...

The clock is ticking for Marsh McLennan as the global insurance brokerage giant prepares to release its third-quarter financial results...

At first glance, Prospect Capital's dividend yield exceeding 20% appears incredibly attractive to income-focused investors. However, this substantial payout comes...

The future of residential solar provider Sunnova Energy now rests with a bankruptcy court, which is poised to deliver a...

Biotechnology firm Denali Therapeutics has encountered a significant regulatory hurdle. The U.S. Food and Drug Administration has postponed its decision...

SolarEdge Technologies is witnessing a significant shift in market sentiment, with prominent financial institutions substantially upgrading their assessments of the...